opensafely / pharmacy-first

MIT License
0 stars 0 forks source link

Define patient populations #1

Open chrisjwood16 opened 3 weeks ago

chrisjwood16 commented 3 weeks ago

There are different eligibility criteria for the pharmacy services of interest. We will need to account for this in our denominator when calculating rates.

Eligibility for each condition taken from: https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN00936_ii_Pharmacy-First-Clinical-Pathways-v.1.6.pdf https://www.england.nhs.uk/wp-content/uploads/2021/11/PRN00173-adv-service-spec-nhs-community-pharmacy-hypertension-case-finding-advanced-service-v2.3.pdf https://www.england.nhs.uk/long-read/nhs-pharmacy-contraception-service/

Clinical pathways:

Condition Age Range Sex Exclusions
Uncomplicated Urinary Tract Infection 16 to 64 years Female Pregnant individuals, urinary catheter, recurrent UTI (2 episodes in last 6 months, or 3 episodes in last 12 months)
Shingles 18 years and over Any Pregnant individuals
Impetigo 1 year and over Any Bullous impetigo, recurrent impetigo (2 or more episodes in the same year), pregnant individuals under 16 years
Infected Insect Bites 1 year and over Any Pregnant individuals under 16 years
Acute Sore Throat 5 years and over Any Pregnant individuals under 16 years
Acute Sinusitis 12 years and over Any Immunosuppressed individuals, chronic sinusitis (symptoms lasting more than 12 weeks), pregnant individuals under 16 years
Acute Otitis Media 1 to 17 years Any Recurrent acute otitis media (3 or more episodes in 6 months or four or more episodes in 12 months), pregnant individuals under 16 years

Hypertension case finding:

Inclusion criteria

Exclusion criteria

Contraception service:

Inclusion criteria: Be an individual seeking to be initiated on an OC, or seeking to obtain a further supply of their ongoing OC:

Exclusion criteria:

chrisjwood16 commented 3 weeks ago

Initial focus should be on clinical pathways and the inclusion criteria. We will need to assess how accurately we can account for the exclusion criteria for the clinical pathways